Oxford BioDynamics (LSE:OBD) Marketable Securities : £1.00 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Oxford BioDynamics's Marketable Securities for the quarter that ended in Sep. 2024 was £1.00 Mil.

Oxford BioDynamics's annual Marketable Securities declined from Sep. 2022 (£0.03 Mil) to Sep. 2023 (£0.00 Mil) but then increased from Sep. 2023 (£0.00 Mil) to Sep. 2024 (£1.00 Mil).

Oxford BioDynamics Marketable Securities Historical Data

The historical data trend for Oxford BioDynamics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Marketable Securities Chart

Oxford BioDynamics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Marketable Securities

Get a 7-Day Free Trial

5.39

2.16

0.03

1.00

Oxford BioDynamics Semi-Annual Data
	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Marketable Securities	Get a 7-Day Free Trial															0.03	2.43	-	-	1.00

Oxford BioDynamics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Oxford BioDynamics (LSE:OBD) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Oxford BioDynamics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

OXBOF:USA LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines